Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug?

CMAJ. Canadian Medical Association Journal

Volumn 161, Issue 1, 1999, Pages 25-32

  Wright, James M ^a   Lee, Cheng Han ^a   Keith Chambers, G ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLOROTHIAZIDE; CHLORTALIDONE; CLONIDINE; DEBRISOQUINE; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GUANETHIDINE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; METHYCLOTHIAZIDE; METHYLDOPA; NIFEDIPINE; NITRENDIPINE; PINDOLOL; PROPRANOLOL; RESERPINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; TRICHLORMETHIAZIDE; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; META ANALYSIS; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 4143106552     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Collins R, Peto R, AlacAIahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
2. Gueyffier F, Froment A, Gouton AI. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hunt Hypmens 1996;IO:!-8.
3. Insua JT, Sacks HS, Lau TS, Lau J, Reitman D, Pagano D, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern MeJ 1994;121:355-62.
4. AlacAIahon S, Rogers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hjpmens 1993;15:967-78.
5. Alulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994;272:1932-8.
6. Thijs L, Fagard R, Lijnen P, Staessen J, Van I loof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. JIfypertms 1992;10:1103-9.
7. Alulrow C, LauJ, Cornell J, Brand AI, Amato AI. Antihypertensive drug therapy in the elderly [Cochrane review]. In: The Cocbrant Library; Issue 3, 1998. Oxford: Update Software.
8. Psaty BAI, Smith NL, Siscovick DS, Koepsell TD, U'eiss NS, I leckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systmatic review and meta-analysis.J JJAM 1997;277:739-45.
9. DerSimonian R, Laird N. Aleta-analysis in clinical trials. Control din Trials 1986;7:177-8.
10. Casiglia E, Spolaore P, Alormino P, Alaschio O, Colangeli G, Celegon L. The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design, and preliminary results of the initial survey. CarJiologia 1991;36(7):569-76.
11. Casiglia E, Spolaore P, Aiazza A, Ginocchio G, Colangeli G, Oncsto C, et al. Effect of two different therapeutic approaches on total and cardiovascular mortality in the Cardiovascular Study in the Elderly (CASTEL). Jpn Heart J 1994;35(5):589-600.
12. CoopeJ, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986;293:1145-51.
13. Philipp T, Anlauf AI, Distler A, Holzgreve H, Alichaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BM] 1997;315:154-9.
14. Hypertension Detection and Follow-up Program Cooperative Group. Fiveyear findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertensionJ JWM 1979;242:2562-71.
15. Hypertension Detection and Follow-up Program Cooperative Group. Fiveyear findings of the Hypertension Detection and Follow-up Program: II. Alortality by race-sex and age. JAMA 1979;242:2572-7.
16. Hypertension Detection and Follow-up Program Cooperative Group. Fiveyear findings of the Hypertension Detection and Follow-up Program: III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982;247:633-8.
17. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in "mild" hypertension. Results of the I lypertension Detection and Follow-up Program. NEnglJMeJ 1982;307:976-80.
18. Hypertension Detection and Follow-up Program Cooperative Group. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris: 5-year findings of the Hypertension Detection and Followup Program. Hypertension 1984;6(1 Suppl):198-206.
19. IPPPSII Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker, oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). Hypertension I985;3:379-92.
20. Wikstrand J, WarnoId I, Tuomilehto J, Olsson G, Barber HJ, Eliasson K, et al. AletoproloI versus thiazide diuretics in hypertension. Morbidity results from the AIAPHY Study. Hypertension I991;17:579-88.
21. Wikstrand J, WamoId I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension. iMortality results from the AIAPIIY study. J JWM 1988;259:1976-82.
22. Alaterson BJ, Reda DJ, Cushman WC, Alassie BM, Freis ED, Kochar AIS, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. NEnglJMeJ 1993;328:914-21.
23. Alaterson BJ, Reda DJ, Cushman WC. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study. Am J Hypertens 1995;8(2): 189-92.
24. Alorgan TO, Adams WR, Hodgson AI, Gibberd RW. Failure of therapy to improve prognosis in elderly males with hypertension. Med J Aust 1980; 2(1):27-31.
25. PATS Collaborating Group. Post-stroke Antihypertensive Treatment Study. A preliminary result. Chin MedJ 1995;108(9):710-7.
26. Gong L, Zwang W, Zhu Y, Zhu J, Kong D, Page V, et al. Shanghai Trial of Nifedipine in the Elderly (STONE) Study .J Hypertens 1996;14:1237-46.
27. Dahlof B, Lindholm LH, Hansson L, Schersten B, Edbom T, Wester PO. Alorbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
28. [Systolic hypertension in the elderly: Chinese trial (Syst-China). Interim report.] ChungHuaHsin HsuebKuanPingTsa Cbih I992;20(5):270-5,323.
29. [Systolic hypertension in the elderly: Chinese trial (Syst-China). Second interim report.) Chung Hua Hsin Hsueb Kimn Ping Tsa Cbib 1993;21(3):135-7,18S.
30. Sprackling AIE, Alitchell JRA, Short AH, Watt G. Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. BMJ 198I;283:1151-3.
31. Strandberg TE, Salomaa W, Naukkarinen VA, Vanhanen HT, Sarna SJ, Aliettinen TA. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 199I;266:1225-9.
32. Treatment of Alild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritionalhygienic regimen along with various drug monotherapies. Ant Intern MeJ 1991;151:14I3-23.
33. Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. Lancet 198I;l:744-7.
34. Berglund G, Andersson O, Widgren B. Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. Acta Med Stand 1986;220:419-24.
35. Wilhelmsen L, Berglund B, Elmfeldt D, Fitzsimons T, Holzgreve H, Hosie J, et al. Beta-blockers versus diuretics in hypertensive men: main results from the IIAPPHY tnA.J Hypertem 19S7;5:561-72.
36. Medical Research Council Working Party. Aledical Research Council trial of treatment of mild hypertension: principal results. B.MJ 1985;291:97-104.
37. Aledical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304: 405-12.
38. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension: II. Results of long-term therapy. JAMrl 1982;248: 2004-11.
39. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris AI, Carr AA, et al. Final outcome results of the Alulti-center Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996;2 76:785-91.
40. Agabiti Rosei E, Dal Pattu D, Leonetti G, Magnani G, Pesssiria A, Zanchetti A. Clinical results of the Verapamil Hypertension and Atherosclerosis Study. JHypertem 1997;! 5:1337-44.
41. Study Group on Long-term Antihypertensive Therapy. A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension -the GLANT Study. Hypertens Res 1995;18:235-44.
42. Australian Therapeutic Trial in Alild Hypertension. Report by the management committee. Lancet I980;l:1261-7.
43. Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial. BMJ 1973;3:434-6.
44. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970;l:485-9.
45. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere AI, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985;I:1349-54.
46. Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974;229:409-18.
47. Kuramoto K, Alatsushita S, Kmvajima I, Alurakami AI. Prospective study on the treatment of mild hypertension in the agcil.Jpn Heart J 1981;22:75-85.
48. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo Study. AmJMcJ 1980;69:725-32.
49. Leren P, Helgeland A. Oslo Hypertension Study. Drug! 1986;31(I Suppl):41-5.
50. Perry HAI Jr, AIcFate Smith W, Alcdonald RH, Black D, Cutler JA, Furberg CD, et al. Alorbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke 1989;20:4-13.
51. Systolic Hypertension in die Elderly Program. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA 1991;265:3255-64.
52. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet I997;350:757-64.
53. United States Public Health Service Hospital Cooperative Study Group. Treatment of mild hypertension. Results of a ten-year intervention trial. Circ Res 1977;40(1 Suppl):98-105.
54. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-34.
55. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JA.\IA 1970;213:1143-52.
56. Perry HM Treatment of mild hypertension -preliminary results of a two-year feasibility trial. Circ Res 1977;40(1 Suppl):180-7.
57. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Alild Hypertension. JInn A'rW Sri 1978;304:267-92.
58. Wolff FW, Lindeman RD. Effects of treatment in hypertension. Results of a controlled study. J Chronic Dis 1966;19:227-40.
59. Holme I. AIAPHY and the two arms of HAPPHY [letter]. JAMA 1989;262:3272-4.
60. Kaplan NAI. Critical comments on recent literature. SCRAAPHY about AIAPHY from HAPPHY. Am JHypenens 1988;1(4 pt 1):428-30.
61. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, et al, for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLILYTMm7 J Jvp?rtf Jtf 1996;9:342-60.
62. Lindholm LH, Hansson L, Dahlof B, Ekbom T, Hedner T, De Faire U, et al. The Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-2): a progress report. Blood Press 1996;5:300-4.
63. Alanagement Committee on behalf of the High Blood Pressure Research Council of Australia. Australian comparative outcome trial of angiotensin-con-verting enzyme inhibitor and diuretic based treatment of hj-pertension in the elderly: objectives and protocol. Clin Erper PbarmacolPath 1997;24:188-92.
64. Kuramoto K. Treatment of elderly hypertensives in Japan: National Intervention Cooperative Study in Elderly Hypertensives. The National Intervention Cooperative Study Group.]' Hjpcrtau Snppl 1994;12(6):S35-40.